Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
This Q3 can be have better result if Spore side revenue is maintain but explain from management is due to timing of project completion/recognition issue.
And China side have impressive progress and it have profit guarantee for two years, so it should be quite consistent.
One thing need to take note is the inorganic grow for company might not stop as it might still have fund raising/borrowing to support the growth plan.
Happy trading!
Booster shots and re-vaccinations could be needed. Drug companies are planning for it. ~ Pfizer CEO: Vaccine third dose 'likely' needed within 12 months
Is bonus for Tasco if really involve in Vaccine delivery, like most of the research house say the contribution might not significant but it will definitely again increase the branding image of Tasco in Malaysia. Does Tasco involve in delivery of Durian “Mustang King “ to China? I believe that will be contribute more to company earning for long run, haha...
Looking back Dnonce price chart, now much lower compare 4months ago as expected, FPE ~10, consider fair value as consider the electronic division. If only compare packaging division, those big compare like TGuan, SCGM, PPHB is more attractive.
